Ladenburg Thalmann Financial Services’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $706K | Buy |
6,756
+3,612
| +115% | +$377K | ﹤0.01% | 1540 |
|
2019
Q3 | $308K | Sell |
3,144
-957
| -23% | -$93.8K | ﹤0.01% | 2153 |
|
2019
Q2 | $538K | Buy |
4,101
+184
| +5% | +$24.1K | ﹤0.01% | 1688 |
|
2019
Q1 | $531K | Buy |
3,917
+218
| +6% | +$29.6K | ﹤0.01% | 1646 |
|
2018
Q4 | $360K | Buy |
3,699
+524
| +17% | +$51K | ﹤0.01% | 1785 |
|
2018
Q3 | $441K | Sell |
3,175
-679
| -18% | -$94.3K | ﹤0.01% | 1707 |
|
2018
Q2 | $429K | Hold |
3,854
| – | – | ﹤0.01% | 1665 |
|
2018
Q1 | $429K | Buy |
3,854
+338
| +10% | +$37.6K | ﹤0.01% | 1665 |
|
2017
Q4 | $422K | Sell |
3,516
-414
| -11% | -$49.7K | ﹤0.01% | 1666 |
|
2017
Q3 | $552K | Buy |
3,930
+294
| +8% | +$41.3K | 0.01% | 1397 |
|
2017
Q2 | $441K | Buy |
3,636
+1,331
| +58% | +$161K | 0.01% | 1465 |
|
2017
Q1 | $279K | Buy |
2,305
+272
| +13% | +$32.9K | ﹤0.01% | 1684 |
|
2016
Q4 | $275K | Buy |
2,033
+209
| +11% | +$28.3K | ﹤0.01% | 1614 |
|
2016
Q3 | $227K | Buy |
1,824
+436
| +31% | +$54.3K | ﹤0.01% | 1677 |
|
2016
Q2 | $161K | Buy |
1,388
+33
| +2% | +$3.83K | ﹤0.01% | 1815 |
|
2016
Q1 | $191K | Sell |
1,355
-394
| -23% | -$55.5K | ﹤0.01% | 1638 |
|
2015
Q4 | $330K | Sell |
1,749
-1,108
| -39% | -$209K | 0.01% | 1258 |
|
2015
Q3 | $448K | Sell |
2,857
-1,739
| -38% | -$273K | 0.01% | 1029 |
|
2015
Q2 | $819K | Buy |
4,596
+1,318
| +40% | +$235K | 0.02% | 816 |
|
2015
Q1 | $567K | Buy |
3,278
+60
| +2% | +$10.4K | 0.01% | 973 |
|
2014
Q4 | $592K | Buy |
3,218
+883
| +38% | +$162K | 0.01% | 837 |
|
2014
Q3 | $387K | Sell |
2,335
-128
| -5% | -$21.2K | 0.01% | 903 |
|
2014
Q2 | $385K | Buy |
2,463
+26
| +1% | +$4.06K | 0.01% | 882 |
|
2014
Q1 | $371K | Sell |
2,437
-3,435
| -58% | -$523K | 0.01% | 846 |
|
2013
Q4 | $780K | Buy |
5,872
+3,407
| +138% | +$453K | 0.02% | 536 |
|
2013
Q3 | $286K | Sell |
2,465
-131
| -5% | -$15.2K | 0.01% | 865 |
|
2013
Q2 | $243K | Buy |
+2,596
| New | +$243K | 0.01% | 897 |
|